糖尿病神经病变的免疫机制和治疗进展
Suli Jiang1, Linxiang Zhang2, Lizhen Zhao1
1Department of Laboratory Medicine, Affiliated Qingdao Third People's Hospital of Qingdao University, Qingdao, 266041, Shandong, China.
Journal of neurology
|January 29, 2026
概括
糖尿病神经病变 (DN) 是一种常见的糖尿病并发症. 持续高血糖会通过炎症和氧化应激损害神经,但像 gabapentin 这样的治疗只能提供部分缓解.
科学领域:
- 内分泌学 在内分泌学.
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 糖尿病神经病变 (DN) 是糖尿病的常见和致残的并发症.
- 它通常表现为远距离对称多神经病变 (DSP),影响四肢的感觉丧失,疼痛和麻木.
- 自主功能障碍和焦点神经损伤也可能发生.
研究的目的:
- 总结一下高血糖导致糖尿病神经病变的神经损伤的机制.
- 要突出糖尿病神经病变的药理干预的最新进展.
- 为DN的机械研究和临床管理提供一个框架.
主要方法:
- 关于糖尿病神经病变的发病和治疗现有文献的综述.
- 在高血糖引起的神经损伤中涉及的关键分子通路的概述.
- 目前用于DN治疗的药理学剂的概述.
主要成果:
- 持续的高血糖导致先进的糖化最终产品 (AGE) 积累,激活RAGE和下游通路 (ROS / NF-κB, JAK / STAT, PKC).
- 高血糖症促进氧化应激,慢性炎症,微血管损伤和施万细胞亡,损害神经修复.
- 目前的治疗方法如 gabapentin,pregabalin 和 α-lipoic acid 提供部分症状缓解.
结论:
- 高血糖引起的神经损伤涉及复杂的机制,包括氧化应激,炎症和修复功能受损.
- 药理干预可以部分缓解DN症状,但不能完全解决潜在的病理问题.
- 需要进一步的研究,以改善糖尿病神经病变的治疗策略.
相关概念视频
01:23Immunological Memory
16.8K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
16.8K
01:20Pathophysiology of Diabetes
3.6K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
01:13Therapeutic Index
6.8K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.8K
02:22Overview of Advanced Functional Groups
29.8K
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
29.8K
00:56Extraction: Advanced Methods
1.1K
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
1.1K
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K